Chimeric Genes in Deletions and Duplications Associated with Intellectual Disability. (24th May 2017)

• Record Type: Journal Article
• Authors: Mayo, Sonia; Monfort, Sandra; Roselló, Mónica; Orellana, Carmen; Oltra, Silvestre; Caro-Llopis, Alfonso; Martínez, Francisco
• Other Names: Salem Mohamed Academic Editor.
• Is Part Of: International journal of genomics. Volume 2017(2017)
• Publication Date: 2017-05-24
• Subjects: Genomes -- Periodicals; Genomics -- Periodicals; Cytogenetics -- Periodicals; Genomics; Genome; Molecular Biology; Cytogenetics; Genomes; Genomics; Periodicals; 572.86
• DOI: 10.1155/2017/4798474
• Languages: English
• ISSNs: 2314-436X

Abstract

Abstract : We report on three nonrelated patients with intellectual disability and CNVs that give rise to three new chimeric genes. All the genes forming these fusion transcripts may have an important role in central nervous system development and/or in gene expression regulation, and therefore not only their deletion or duplication but also the resulting chimeric gene may contribute to the phenotype of the patients. Deletions and duplications are usually pathogenic when affecting dose-sensitive genes. Alternatively, a chimeric gene may also be pathogenic by different gain-of-function mechanisms that are not restricted to dose-sensitive genes: the emergence of a new polypeptide that combines functional domains from two different genes, the deregulated expression of any coding sequence by the promoter region of a neighboring gene, and/or a putative dominant-negative effect due to the preservation of functional domains of partially truncated proteins. Fusion oncogenes are well known, but in other pathologies, the search for chimeric genes is disregarded. According to our findings, we hypothesize that the frequency of fusion transcripts may be much higher than suspected, and it should be taken into account in the array-CGH analyses of patients with intellectual disability.